Coldflu

Clinical Trials

Extensive clinical data available for individual components (Paracetamol, Phenylephrine, Chlorpheniramine). Combination efficacy and safety are well-established through post-marketing surveillance and recognized therapeutic guidelines.

Lab Monitoring

• Liver function tests (in prolonged use or high doses of Paracetamol)
• Blood pressure monitoring (due to Phenylephrine)
• Renal function in patients with kidney impairment.

Doctor Notes

• Advise patients that this medication provides symptomatic relief and is not a cure for viral infections. Emphasize not to exceed recommended doses due to potential for liver toxicity (Paracetamol) and cardiovascular effects (Phenylephrine). Caution in patients with pre-existing conditions like hypertension, diabetes, glaucoma, or prostate enlargement due to decongestant/antihistamine components. Monitor for signs of liver toxicity with prolonged use.
• Instruct patients to seek medical advice if symptoms persist beyond 5-7 days or if new symptoms develop.

Patient Guidelines

• Do not exceed recommended dose and duration of treatment.
• Avoid alcohol while taking this medicine.
• May cause drowsiness, use caution when driving or operating machinery.
• Consult a doctor if symptoms persist beyond 7 days or worsen.
• Keep out of reach of children.

Missed Dose Advice

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not double the dose.

Driving Precautions

This medicine may cause drowsiness or dizziness. Avoid driving or operating heavy machinery until you know how it affects you.

Lifestyle Advice

• Ensure adequate rest and hydration.
• Avoid exposure to cold/flu triggers.
• Maintain good hygiene to prevent spread of infection, such as frequent hand washing.
• Avoid smoking and excessive caffeine.